Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison between single subcutaneous glargine injection and continuous regular insulin infusion for glycemic control in critically ill patients
TCTR20160126004Phase 2Completed
- Sponsor
- Nil
- Start
- Oct 2014
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of insulin glargine, human insulin in hyperglycemia, diabetes mellitus (DM), sponsored by Nil. Started Oct 2014; status: completed.
02
Drugs
insulin glarginehuman insulin
03
Conditions
hyperglycemiadiabetes mellitus (DM)
Beyond the preview
Go deeper on TCTR20160126004.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20160126004.